[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100510006":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":20,"locations":25,"responsibleParty":41,"collaborators":7,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":7,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":7,"enrollmentInfo":52,"targetDuration":55,"studyType":56,"phases":7,"briefSummary":57,"conditions":58,"keywords":7,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":71},{"fullName":5,"class":6},"Barts & The London NHS Trust","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","Echocardiogram","Ultrasound scan of the heart",[14,17],{"name":15,"affiliation":5,"role":16},"Sanjeev bhattacharyya","PRINCIPAL_INVESTIGATOR",{"name":18,"affiliation":5,"role":19},"Jawza Aldakhil","STUDY_CHAIR",[21],{"name":18,"role":22,"phone":23,"phoneExt":7,"email":24},"CONTACT","00447899770693","Jawza@outlook.sa",[26],{"facility":27,"status":28,"city":29,"state":7,"zip":7,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"St Bartholomew's Hospital","RECRUITING","London","United Kingdom","UK",{"type":33,"coordinates":34},"Point",[35,36],-0.12574,51.50853,{"lat":36,"lon":35},[39],{"name":18,"role":22,"phone":7,"phoneExt":7,"email":40},"jawza.aldakhil@nhs.net",{"type":42,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100510006","atrial-functional-mitral-regurgitation-and-tricuspid-regurgitation-100510006",false,"NCT05920824","Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation","Clinical Phenotypes, Risk Factors, & Determinants of Outcome in Functional Mitral and Tricuspid Valve Regurgitation","Inclusion Criteria:\n\n* Informed consent\n* Age of 18 years or older\n* Atrial fibrillation\n* Moderate or severe atrial valve disease\n* Adequate 2D echocardiography views including parasternal long axis, short axis, apical two chamber, apical three chamber and four chamber.\n\nExclusion Criteria:\n\n* Unwilling or unable to give consent\n* Left ventricular impairment (ejection fraction \\\u003C 50%).\n* Primary\u002Forganic valve disease","ALL","18 Years",{"count":53,"type":54},141,"ESTIMATED","1 Year","OBSERVATIONAL","A prospective, observational cohort study designed to identify clinical phenotypes and evaluate predictors \\& outcomes of functional mitral and tricuspid valve regurgitation in patients with atrial fibrillation.\n\nParticipant will under go:\n\n* Baseline echocardiography\n* Cpex Echocardiography\n* Blood test: BNP\n* 1 year follow up Echocardiography\n\nParticipants will be stratified into three subgroups:\n\n* Atrial Functional MR\n* Atrial Functional TR\n* Mixed MR \\& TR",[59,60,61],"Atrial Fibrillation","Functional Mitral Regurgitation","Functional Tricuspid Regurgitation","2026-04-20",{"date":64,"type":65},"2026-04-21","ACTUAL",{"date":67,"type":65},"2023-08-23",{"date":69,"type":54},"2027-08",{"name":5,"class":6},1]